Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

10.7K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.7K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

732
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
732

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatiotemporal dynamics of tau extent and load increase in Alzheimer's disease across four longitudinal cohorts.

Nature aging·2026
Same author

Plasma Proteomic Changes in GRN and C9orf72 Frontotemporal Dementia.

European journal of neurology·2026
Same author

Sex-specific associations between astrocytic reactivity and cognitive decline in unimpaired elderly.

bioRxiv : the preprint server for biology·2026
Same author

Plasma proteomic profiles of Alzheimer's disease and neurodegeneration in African cohorts.

Nature communications·2026
Same author

[<sup>18</sup>F]RO948 Tau PET in early and late onset Alzheimer's disease: associations with plasma p-tau 217, atrophy and cognition.

European journal of nuclear medicine and molecular imaging·2026
Same author

Aβ- and tau-associated neuroinflammatory signatures in Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)·2026

Related Experiment Video

Updated: Oct 10, 2025

Visualization of Amyloid &#946; Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

10.8K

Soluble amyloid-beta isoforms predict downstream Alzheimer's disease pathology.

Guilherme Povala1,2, Bruna Bellaver1, Marco Antônio De Bastiani1

  • 1Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.

Cell & Bioscience
|December 13, 2021
PubMed
Summary

Soluble amyloid-beta (Aβ) levels in cerebrospinal fluid (CSF) can predict tau pathology and neurodegeneration in cognitively unimpaired individuals. Machine learning models achieved high accuracy, identifying key biological processes for further Alzheimer's disease research.

Keywords:
Alzheimer’s diseaseAmyloid-betaMachine learningNeurodegenerationProteomicsTau pathology

More Related Videos

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

4.1K
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

12.0K

Related Experiment Videos

Last Updated: Oct 10, 2025

Visualization of Amyloid &#946; Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

10.8K
Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

4.1K
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

12.0K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Computational Biology

Background:

  • Soluble amyloid-beta (Aβ) levels in cerebrospinal fluid (CSF) are early indicators of Alzheimer's disease (AD).
  • Predictive value of Aβ isoforms for downstream tau pathology (T+) and neurodegeneration (N+) in cognitively unimpaired (CU) individuals remains unclear.

Purpose of the Study:

  • To investigate if combined soluble Aβ isoforms can predict T+ and N+ positivity in CU individuals.
  • To explore biological processes altered in individuals with predicted T+ and N+ using proteomics.

Main Methods:

  • Machine learning (ML) models were trained using CSF Aβ1-38, Aβ1-40, and Aβ1-42 measurements from 318 CU individuals.
  • 2046 predictive ML models were built using nested cross-validation.
  • Proteomics data analyzed for functional enrichment of differentially expressed proteins (DEPs) in misclassified individuals.

Main Results:

  • Aβ isoforms accurately predicted T+ (AUC=0.929) and N+ (AUC=0.936).
  • Proteomics identified 17 DEPs in misclassified individuals.
  • Enrichment analysis revealed altered myelinization, glucose metabolism, amino acid biosynthesis, and cell adhesion pathways.

Conclusions:

  • Refined ML analysis demonstrates high predictive accuracy of Aβ isoforms for T+ and N+.
  • CSF proteomics identified potential biomarkers for improving T+ and N+ prediction in early AD stages.